From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy
Biomarker-driven frameworks now guide which patients will benefit from immunotherapy, reducing unnecessary treatment and side effects.
This European Journal of Cancer review examines biomarker discovery and predictive modeling approaches for personalizing immune checkpoint blockade therapy. It covers emerging frameworks for treatment selection in precision oncology.
What the study was
- Study design
- Review
- Population
- Cancer patients receiving immune checkpoint blockade
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- European Journal of Cancer
Why it surfaced
Highly relevant review in EJC on ICI biomarker prediction. Top-tier journal placement.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.